# Advisor Review - GPT-5.2

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-02-26T13:23:15.558959
**Route:** OpenRouter + LaTeX
**Paper Hash:** 0dbeb563e0ebe8ff
**Tokens:** 20800 in / 1193 out
**Response SHA256:** b000cf4d3e824b5c

---

No fatal errors detected in the four categories you specified (data-design alignment, regression sanity, completeness, internal consistency). Key checks:

- **Data–design alignment:** Treatment/post periods (March 2020 for COVID; April 2021 for ARPA) are within the stated data window **Jan 2018–Dec 2024**. All cohorts/windows used in DiD/event-study/DDD have post-treatment observations. Exit-rate construction (active 2018–2019; “exited” = no billing after Feb 2020) is feasible with the available months.
- **Regression sanity:** All reported coefficients/SEs are finite and plausible for log outcomes; no “NA/NaN/Inf,” no impossible \(R^2\), no absurd SE magnitudes indicating obvious collinearity artifacts.
- **Completeness:** Regression tables report **standard errors and sample sizes (Observations)**; no “TBD/TODO/XXX” placeholders in tables. Figures are referenced and included via `\includegraphics` (cannot verify file presence from LaTeX alone, but no internal “missing figure/table” references in the source).
- **Internal consistency:** Sample size arithmetic matches the panel dimensions (e.g., HCBS-only state-month panel \(51\times 84 = 4{,}284\); state×type×month panel \(51\times 2\times 84 = 8{,}568\)). Treatment dates are consistent across sections/tables.

ADVISOR VERDICT: PASS